FNCMX vs. FBIOX
Compare and contrast key facts about Fidelity NASDAQ Composite Index Fund (FNCMX) and Fidelity Select Biotechnology Portfolio (FBIOX).
FNCMX is managed by Fidelity. FBIOX is managed by Fidelity. It was launched on Dec 16, 1985.
Performance
FNCMX vs. FBIOX - Performance Comparison
Loading graphics...
FNCMX vs. FBIOX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FNCMX Fidelity NASDAQ Composite Index Fund | -6.99% | 21.11% | 29.48% | 45.13% | -32.40% | 22.21% | 44.57% | 36.63% | -3.07% | 28.35% |
FBIOX Fidelity Select Biotechnology Portfolio | 2.11% | 36.38% | 7.26% | 10.09% | -15.87% | -12.26% | 38.62% | 36.12% | -10.92% | 27.87% |
Returns By Period
In the year-to-date period, FNCMX achieves a -6.99% return, which is significantly lower than FBIOX's 2.11% return. Over the past 10 years, FNCMX has outperformed FBIOX with an annualized return of 16.86%, while FBIOX has yielded a comparatively lower 10.44% annualized return.
FNCMX
- 1D
- 3.83%
- 1M
- -5.04%
- YTD
- -6.99%
- 6M
- -4.89%
- 1Y
- 24.46%
- 3Y*
- 21.83%
- 5Y*
- 10.80%
- 10Y*
- 16.86%
FBIOX
- 1D
- 5.51%
- 1M
- -1.00%
- YTD
- 2.11%
- 6M
- 15.61%
- 1Y
- 46.30%
- 3Y*
- 19.65%
- 5Y*
- 4.79%
- 10Y*
- 10.44%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FNCMX vs. FBIOX - Expense Ratio Comparison
FNCMX has a 0.29% expense ratio, which is lower than FBIOX's 0.69% expense ratio.
Return for Risk
FNCMX vs. FBIOX — Risk / Return Rank
FNCMX
FBIOX
FNCMX vs. FBIOX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity NASDAQ Composite Index Fund (FNCMX) and Fidelity Select Biotechnology Portfolio (FBIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FNCMX | FBIOX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.10 | 1.70 | -0.59 |
Sortino ratioReturn per unit of downside risk | 1.70 | 2.26 | -0.56 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.29 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 1.92 | 2.86 | -0.94 |
Martin ratioReturn relative to average drawdown | 7.03 | 11.00 | -3.97 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FNCMX | FBIOX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.10 | 1.70 | -0.59 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.48 | 0.19 | +0.29 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.77 | 0.40 | +0.37 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.53 | 0.48 | +0.05 |
Correlation
The correlation between FNCMX and FBIOX is 0.67, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
FNCMX vs. FBIOX - Dividend Comparison
FNCMX's dividend yield for the trailing twelve months is around 0.55%, less than FBIOX's 2.42% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FNCMX Fidelity NASDAQ Composite Index Fund | 0.55% | 0.51% | 0.61% | 0.67% | 0.88% | 0.47% | 0.67% | 4.41% | 1.93% | 0.03% | 1.01% | 1.50% |
FBIOX Fidelity Select Biotechnology Portfolio | 2.42% | 2.47% | 1.21% | 0.45% | 0.00% | 14.48% | 19.46% | 8.89% | 11.18% | 1.41% | 3.42% | 6.71% |
Drawdowns
FNCMX vs. FBIOX - Drawdown Comparison
The maximum FNCMX drawdown since its inception was -55.08%, smaller than the maximum FBIOX drawdown of -71.98%. Use the drawdown chart below to compare losses from any high point for FNCMX and FBIOX.
Loading graphics...
Drawdown Indicators
| FNCMX | FBIOX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.08% | -71.98% | +16.90% |
Max Drawdown (1Y)Largest decline over 1 year | -13.25% | -12.27% | -0.98% |
Max Drawdown (5Y)Largest decline over 5 years | -35.64% | -44.87% | +9.23% |
Max Drawdown (10Y)Largest decline over 10 years | -35.64% | -48.66% | +13.02% |
Current DrawdownCurrent decline from peak | -9.68% | -2.21% | -7.47% |
Average DrawdownAverage peak-to-trough decline | -7.91% | -23.72% | +15.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.61% | 3.57% | +0.04% |
Volatility
FNCMX vs. FBIOX - Volatility Comparison
The current volatility for Fidelity NASDAQ Composite Index Fund (FNCMX) is 6.98%, while Fidelity Select Biotechnology Portfolio (FBIOX) has a volatility of 9.24%. This indicates that FNCMX experiences smaller price fluctuations and is considered to be less risky than FBIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FNCMX | FBIOX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.98% | 9.24% | -2.26% |
Volatility (6M)Calculated over the trailing 6-month period | 13.04% | 15.54% | -2.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.31% | 24.47% | -1.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.47% | 24.93% | -2.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.01% | 26.43% | -4.42% |